Effect of ETA receptor antagonist on pulmonary hypertension and vascular reactivity in rats with congestive heart failure

Pulmonary Pharmacology and Therapeutics

Volumn 14, Issue 4, 2001, Pages 307-314

  Lucas, M ^a   Jasmin, J F ^a   Dupuis, J ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Endothelial receptors; Endothelins; Endothelium; Heart failure; Pulmonary circulation

Indexed keywords

ACETYLCHOLINE; DARUSENTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; NITROPRUSSIDE SODIUM; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG EFFECT; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE HYPERTROPHY; ISOLATED LUNG; LONG TERM CARE; LUNG CIRCULATION; LUNG ENDOTHELIUM; LUNG VASOCONSTRICTION; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; RECEPTOR BLOCKING; VASODILATATION;

EID: 0034939905     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.2001.0298     Document Type: Article

References (24)

1. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy
2. Pulmonary hypertension and exercise intolerance in patients with heart failure
3. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
4. BQ123, an ETA-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats
5. The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphenyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats
6. Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. Increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lung in congenstive heart failure in rats
7. Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease?
8. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure
9. Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat
10. Endothelin-A receptor antagonism in rats with myocardial infarction and failure
11. Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure
12. Endothelin A receptor blockade improves nitric oxide-mediated vasodilation in monocrotaline-induced pulmonary hypertension
13. Effects of chronic ETA-receptor blockade in angiotensin I-induced hypertension
14. Myocardial infarct size and ventricular function in rats
15. A receptor antagonist: LU 135252
16. Impaired nitric oxide-dependent responses and their recovery in hypertensive pulmonary arteries of rats
17. L-arginine restores endothelium-dependent relaxation in pulmonary circulation of chronically hypoxic rats
18. Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure
19. Eicosanoid production in isolated perfused lungs stimulated by calcium ionophore A23187
20. Influence of the thromboxane antagonist BM 13.177 on the arachidonic acid-induced increase in pulmonary vascular resistance and permeability in rabbit lungs
21. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide
22. Identification of endothelin 1 and big endothelin 1 in secretory vesicles isolated from bovine aortic endothelial cells
23. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension
24. Endothelin-dependent tone limits acetylcholine-induced dilation of resistance coronary vessels after blockade of NO formation in conscious dogs